Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.

Bendre, A R; Gangal, S G

Bendre, A R; Gangal, S G.

Indian J Cancer ; 1978 Dec; 15(4): 9-16

Article in English | IMSEAR | ID: sea-49748

Subject(s)

Adjuvants, Immunologic/therapeutic use; Animals; Antibodies, Neoplasm/analysis; Antigens, Neoplasm/analysis; Cytotoxicity Tests, Immunologic; Fibrosarcoma/immunology; Graft Rejection/radiation effects; Leukocyte Count; Lymphocytes/immunology; Mice; Neoplasm Transplantation; Sarcoma, Experimental/immunology; Vaccinia virus/immunology

Fulltext

XML

Search on Google

Full text: Available Index: IMSEAR (South-East Asia) Main subject: Sarcoma, Experimental / Vaccinia virus / Cytotoxicity Tests, Immunologic / Lymphocytes / Adjuvants, Immunologic / Fibrosarcoma / Graft Rejection / Leukocyte Count / Animals / Mice Language: English Journal: Indian J Cancer Year: 1978 Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google